The life science sector is undergoing a transformation such that healthcare technologies are often combined in integrated systems that can include diagnostics, pharmaceuticals, devices and digital health solutions. As a result, market access actors and decision processes need to adapt to these developments so as to better assess the relative value of new technologies. These changes bring both challenges and opportunities, and we believe that thanks to our multisectoral market access expertise, we are able to help customers navigate this complex environment and identify the best solutions for them.